• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牙周状况与重度抑郁症一线治疗的疗效。

Periodontal status and the efficacy of the first-line treatment of major depressive disorder.

机构信息

Department for Extended Treatment and Palliative Care of Men, University Psychiatric Hospital "Sveti Ivan", Zagreb, Croatia.

Research Unit "Dr. Mirko Grmek", University Psychiatric Hospital "Sveti Ivan", Zagreb, Croatia.

出版信息

Clin Exp Dent Res. 2022 Feb;8(1):366-373. doi: 10.1002/cre2.492. Epub 2021 Nov 3.

DOI:10.1002/cre2.492
PMID:34729949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8874085/
Abstract

OBJECTIVES

The efficacy of treatment of major depressive disorder (MDD) is not satisfactory. Systemic inflammation may play an important role in MDD pathogenesis and treatment outcomes. Periodontal disease is the systemic inflammatory condition. Its prevalence may be as high as 45%. We aimed to assess the association of periodontal status with the outcome of 3-month first-line treatment of MDD with selective serotonin reuptake inhibitors.

MATERIAL AND METHODS

We performed the prospective cohort study during 2018/2019 at Psychiatric Hospital "Sveti Ivan," Croatia, on a consecutive sample of 43 patients. The outcome was the MDD symptoms severity measured using the Hamilton Depression Rating Scale-17. The periodontal status was indicated by the clinical attachment loss (CAL).

RESULTS

Baseline periodontal status had a nonlinear significant and clinically relevant association with the MDD treatment outcome (R change of the quadratic term = 0.12; p = 0.027). In patients with good baseline periodontal status the severity of MDD symptoms was significantly improved. When the value of CAL was ≥4.44 mm, indicating the worse periodontal status, further increase in baseline CAL was associated with the worsening of MDD treatment outcomes independently of the baseline depression severity and 14 sociodemographic and clinical predictors of treatment outcome.

CONCLUSIONS

Periodontal healthcare is accessible, and should be utilize in an integrative, multidisciplinary approach not only for the sake of psychiatric patients' quality of life and prevention of periodontal disease, but for the sake of the outcomes of psychiatric treatment as well.

摘要

目的

重度抑郁症(MDD)的治疗效果并不令人满意。全身炎症可能在 MDD 的发病机制和治疗结果中起重要作用。牙周病是一种全身性炎症疾病,其患病率可能高达 45%。我们旨在评估牙周状况与选择性 5-羟色胺再摄取抑制剂(SSRIs)治疗 MDD 三个月一线治疗结果的相关性。

材料与方法

我们在 2018/2019 年期间在克罗地亚的斯韦蒂·伊万精神病院进行了这项前瞻性队列研究,纳入了连续的 43 名患者。结局是使用汉密尔顿抑郁评定量表-17 测量的 MDD 症状严重程度。牙周状况由临床附着丧失(CAL)表示。

结果

基线牙周状况与 MDD 治疗结果呈显著非线性相关,且具有临床意义(二次项的 R 变化=0.12;p=0.027)。在基线牙周状况良好的患者中,MDD 症状的严重程度显著改善。当 CAL 值≥4.44 mm 时,表明牙周状况较差,进一步增加基线 CAL 与 MDD 治疗结果恶化独立相关,与基线抑郁严重程度以及 14 项治疗结果的社会人口学和临床预测因素无关。

结论

牙周保健是可行的,应在综合、多学科的方法中利用,不仅为了精神病患者的生活质量和预防牙周病,也为了精神病治疗的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e4/8874085/ce07d830dbe5/CRE2-8-366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e4/8874085/88de0fb45daf/CRE2-8-366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e4/8874085/ce07d830dbe5/CRE2-8-366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e4/8874085/88de0fb45daf/CRE2-8-366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e4/8874085/ce07d830dbe5/CRE2-8-366-g001.jpg

相似文献

1
Periodontal status and the efficacy of the first-line treatment of major depressive disorder.牙周状况与重度抑郁症一线治疗的疗效。
Clin Exp Dent Res. 2022 Feb;8(1):366-373. doi: 10.1002/cre2.492. Epub 2021 Nov 3.
2
Efficacy, Safety and Tolerability of Augmentative rTMS in Treatment of Major Depressive Disorder (MDD): A Prospective Cohort Study in Croatia.增效重复经颅磁刺激治疗重度抑郁症(MDD)的疗效、安全性和耐受性:克罗地亚的一项前瞻性队列研究
Psychiatr Danub. 2017 Mar;29(1):31-38. doi: 10.24869/psyd.2017.31.
3
A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.描述性分析自然环境下门诊重度抑郁症患者使用患者报告结局测量量表评估的生活质量。
Qual Life Res. 2013 Apr;22(3):585-96. doi: 10.1007/s11136-012-0187-6. Epub 2012 Apr 29.
4
Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study.与居住在 12 个不同国家的 2 型糖尿病成人中重度抑郁症发病相关的因素:INTERPRET-DD 前瞻性研究结果。
Epidemiol Psychiatr Sci. 2020 Jun 2;29:e134. doi: 10.1017/S2045796020000438.
5
Major depressive disorder in hemodialysis patients in China.中国血液透析患者中的重度抑郁症
Asia Pac Psychiatry. 2015 Mar;7(1):78-84. doi: 10.1111/appy.12110. Epub 2013 Nov 21.
6
Psychomotor retardation and vulnerability to interferon alpha induced major depressive disorder: Prospective study of a chronic hepatitis C cohort.精神运动迟缓与对干扰素α诱发的重度抑郁症的易感性:一项慢性丙型肝炎队列的前瞻性研究。
J Psychosom Res. 2015 Dec;79(6):640-5. doi: 10.1016/j.jpsychores.2015.06.003. Epub 2015 Jun 18.
7
An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.度洛西汀治疗肠易激综合征合并重度抑郁症患者的开放标签试点研究。
J Clin Psychopharmacol. 2016 Dec;36(6):710-715. doi: 10.1097/JCP.0000000000000599.
8
Association of quality of life with major depressive disorder among people with HIV in South India.印度南部HIV感染者中生活质量与重度抑郁症的关联
AIDS Care. 2013;25(2):169-72. doi: 10.1080/09540121.2012.689809. Epub 2012 May 29.
9
Prevalence and predictors of pain in patients with major depressive disorder.重度抑郁症患者的疼痛患病率及预测因素。
Asian J Psychiatr. 2013 Aug;6(4):288-91. doi: 10.1016/j.ajp.2012.12.004. Epub 2013 Jan 23.
10
Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort.精神分裂症合并重性抑郁障碍患者的抑郁缓解:来自 FACE-SZ 队列的结果。
Br J Psychiatry. 2018 Aug;213(2):464-470. doi: 10.1192/bjp.2018.87. Epub 2018 Jun 6.

引用本文的文献

1
Evaluation of the Effect of Escitalopram on Alveolar Bone Levels and Periodontal Parameters: A Case-Control Study.艾司西酞普兰对牙槽骨水平和牙周参数影响的评估:一项病例对照研究。
Int J Dent. 2025 Jul 24;2025:8637908. doi: 10.1155/ijod/8637908. eCollection 2025.

本文引用的文献

1
Periodontal diseases and depression: A pre-clinical in vivo study.牙周病与抑郁症:一项临床前体内研究。
J Clin Periodontol. 2021 Apr;48(4):503-527. doi: 10.1111/jcpe.13420. Epub 2021 Feb 9.
2
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
3
Recent epidemiologic trends in periodontitis in the USA.
美国牙周炎的近期流行病学趋势。
Periodontol 2000. 2020 Feb;82(1):257-267. doi: 10.1111/prd.12323.
4
Inflammation and the dimensions of depression: A review.炎症与抑郁的维度:综述。
Front Neuroendocrinol. 2020 Jan;56:100800. doi: 10.1016/j.yfrne.2019.100800. Epub 2019 Oct 22.
5
Current Knowledge on Correlations Between Highly Prevalent Dental Conditions and Chronic Diseases: An Umbrella Review.当前关于高发牙科状况与慢性疾病相关性的知识:伞式综述。
Prev Chronic Dis. 2019 Sep 26;16:E132. doi: 10.5888/pcd16.180641.
6
Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.外周细胞因子水平与抗抑郁治疗反应在抑郁症中的系统评价和荟萃分析。
Mol Psychiatry. 2020 Feb;25(2):339-350. doi: 10.1038/s41380-019-0474-5. Epub 2019 Aug 19.
7
Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation.慢性肾脏病和肾移植患者牙周病的病理特征。
Int J Mol Sci. 2019 Jul 11;20(14):3413. doi: 10.3390/ijms20143413.
8
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness.《柳叶刀》精神病学委员会:保护精神疾病患者身体健康的蓝图。
Lancet Psychiatry. 2019 Aug;6(8):675-712. doi: 10.1016/S2215-0366(19)30132-4. Epub 2019 Jul 16.
9
Inflammation and depression but where does the inflammation come from?炎症和抑郁,但炎症从何而来?
Curr Opin Psychiatry. 2019 Sep;32(5):422-428. doi: 10.1097/YCO.0000000000000531.
10
Prognosis and improved outcomes in major depression: a review.重度抑郁症的预后和改善结果:综述。
Transl Psychiatry. 2019 Apr 3;9(1):127. doi: 10.1038/s41398-019-0460-3.